AI-Driven Biomarkers in Pediatric Neuropathology

AI is advancing the identification and analysis of biomarkers in pediatric neuropathology, aiding in the early diagnosis and monitoring of neurological disorders. By analyzing tissue samples and imaging data, machine learning algorithms can detect subtle changes that may indicate disease progression or response to treatment. This session will focus on how AI is uncovering new biomarkers for conditions like brain tumors, neurodegenerative diseases, and genetic disorders, improving diagnosis and personalized care for pediatric patients.

    Related Conference of AI-Driven Biomarkers in Pediatric Neuropathology

    June 29-30, 2026

    6th Global Summit on Pediatric Nursing

    Barcelona, Spain
    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    October 05-06, 2026

    39th World Pediatrics Conference

    Madrid, Spain
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE
    December 03-04, 2026

    11th Annual Pediatric Congress

    Madrid, Spain
    December 29-30, 2026

    35th World Congress on Clinical Pediatrics

    Edinburgh, Scotland

    AI-Driven Biomarkers in Pediatric Neuropathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in